4th Annual National Opioid Crisis Management Congress
September 9-10, 2019 * Fairmont Scottsdale Princess Scottsdale, AZ

4th Annual National Opioid Crisis Management Congress

Day(s)

:

Hour(s)

:

Minute(s)

:

Second(s)

About the Conference

National attention is focused on the opioid crisis, and communities are struggling to respond. According to the U.S. Centers for Disease Control, as the clinical use of opioids has risen over the past two decades, opioid-associated harm has risen in parallel.

Chronic pain affects approximately 100 million Americans, making it one of the most common reasons for patients to seek medical care. Over the past decade there has been a four-fold increase in opioid prescribing. During the same time period there was a four-fold increase in unintentional opioid overdose deaths, and a five-fold increase in substance abuse treatment admissions for prescription opioid addiction.

The ongoing opioid crisis lies at the intersection of two substantial public health challenges—reducing the burden of suffering from pain and containing the rising toll of the harms that can arise from the use of opioid medications.

This conference will address the state of the science in pain management, characterize the epidemiology of the opioid epidemic, and identify actions that can be taken to respond to this crisis. Gain expert insight into an epidemic from top thought leaders in opioid management who will share their latest research and real world knowledge in the evolving paradigm of opioids in medicine. In addition, experts at the state and federal levels providing leadership on the opioid public health crisis will present developing collaborative strategic partnerships to serve our most vulnerable citizens.

Who Should Attend?

From Hospitals/Health Systems/Health Plans/Gov’t Agencies/Law Enforcement

  • CEO
  • CFO
  • VP
  • Medical Directors
  • Behavioral Health Directors
  • Pharmacy Directors
  • Clinical Pharmacists
  • Social Workers
  • Outreach Coordinators
  • PDMP Directors
  • Pain Management Directors
  • Psychiatrists
  • Psychologists
  • Telehealth Directors
  • State Health Directors
  • Nursing Director
  • Emergency Room Directors
  • Substance Abuse & Prevention Directors
  • Pediatricians
  • Law Enforcement
  • Narcotic Enforcement
  • Physicians
  • Quality Improvement Director
  • Family Services Director
  • Clinical Directors
  • Investigators
  • Compliance Director
  • Correctional Coordinators

This Event Will Also be if Interest to:

  • Pharmaceutical Companies * Law Firms * Consultants * Drug Development Companies * Vendors * Solution Providers

Conference Agenda

Day One – Monday, September 9, 2019

7:15am – 8:00am

Conference Registration & Networking Breakfast

8:00am – 8:15am

Chairperson’s Opening Remarks

8:15am – 9:00am

Keynote

The Opioid Crisis: Federal and State Regulation of Opioids

This keynote will address federal and state regulations that are swiftly changing to address the current opioid epidemic.

9:00am – 9:45am

Safer and Effective Opioid Prescribing Practices

Providers who prescribe opioids to treat chronic pain are in a key position to balance the benefits and risks of chronic opioid therapy (COT). However, providers struggle with the need to assist their patients with adequate management of chronic pain while confronting the risks associated with opioid prescribing. This session will provide recommendations for safer and more effective prescribing of opioids. Topics will include:

- Identify opioid practice updates as outlined in the CDC opioid guidelines
- Monitoring and documentation strategies to meet best practice standards and medical and legal requirements
- Apply a practical framework for decision-making on the initiation, dosage modification, and when and how opioids should be discontinued
- Tools to adequately assess risk in patients being considered for opioid therapy
- Limiting the use of opioid prescriptions for combatting pain and recommending new treatments for pain management without the use of addictive substances

9:45am – 10:15am

Networking & Refreshments Break

10:15am – 11:00am

How Insurers Can Help Fight the Opioid Epidemic

Of the approximately 100 million Americans who take prescription opioids each year, almost 3 million receive their prescriptions from five to as many as 20 different physicians. The practice, often called “doctor shopping,” allows opioid-addicted individuals to consume an enormous and dangerous number of pills with the unwitting help of doctors. Doctor shopping also lets drug dealers use the healthcare system to subsidize their business. Doctor shopping is possible because none of the doctor shoppers’ prescribers knows that they are only one of many providers of opioids. Enter someone with full information: the insurer. This session will discuss the role of health plans in curbing the opioid crisis. Topics will include:

- Using innovative data analysis to monitor opioid prescribing of providers
- “Reimbursement lock-in,” (when the enrollee’s prescriptions for opioids will only be covered if they are written by a single provider of the patient’s choosing)
- Implementing a pharmacist-led medication therapy management program
- Steps to curb the abuse of opioid prescriptions

11:00am – 11:45am

Medication-Assisted Treatment and New Models of Care for Opioid Use Disorder

The occurrence of opioid use disorder (OUD, opioid abuse/addiction) is a concern shared by many clinicians who prescribe opioids in the context of pain management. This session will review rates of OUD in chronic pain patients, behaviors associated with OUD, and epidemiology of OUD in Americans and treatment of OUD. Medication assisted treatment for OUD will be addressed as will new models of care for this population.

11:45am – 1:00pm

Lunch

1:00pm – 1:45pm

FDA Perspective: Regulatory Requirements and Evolving Methods of Abuse Deterrent Approaches

A call for informed professionals to engage in a discussion of timely opioid-related policy matters, this session will address the regulatory requirements and evolving methods for evaluating abuse deterrent approaches, as well as emerging data to determine if an abuse deterrent approach is effective in mitigating prescription opioid abuse and misuse. Topics will include:

- The assessment, treatment and outcomes of pain in patients at risk for prescription opioid abuse
- Broader policy initiatives, including the FDA’s requirement for black box warnings on all prescription opioids

1:45pm – 2:30pm

Collaboration Between Opioid Treatment Programs and Community Partners

Reducing the Community Prescribed Opioid Load as a Harm Reduction Strategy
In response to the heightened risks associated with the use of opioids, this session will discuss community safety strategies to reduce the harm imposed by opioids on communities, and help to control the opioid epidemic. Topics will include:

- Best practice in opioid prescribing and monitoring to reduce the quantity of opioids in circulation
- Strategies to assist healthcare partnerships and collaborations by advancing their understanding of medication assisted treatment as a crucial element to community wellness in an era of healthcare reform
- The essential role that the community plays in recovery support and prevention

2:30pm – 3:00pm

Networking & Refreshments Break

3:00pm – 4:15pm

Panel

Responding to a Public Health Crisis: Opioid Use, Misuse and Abuse

This session will provide an overview of practical tools and strategies to understand the critical aspects of prescription pain medications while managing the ever-increasing challenges associated with prescribing opioids. It will include a framework for considerations of opioid therapy in treatment regimens and address concerns that arise in the practice setting.

4:15pm – 5:00pm

Integrated and Coordinated Opioid Treatment Care

Research has proven that effective care coordination increases efficiency and improves clinical outcomes and patient satisfaction. This session will assist you in the development of strategies to improve the collaboration between opioid treatment providers and the systems needed to coordinate care.

5:00pm

End of Day One

Day Two – Tuesday, September 10, 2019

7:15am – 8:00am

Networking Breakfast

8:00am – 8:15am

Chairperson’s Remarks

8:15am – 9:00am

State Medical Board Perspective

This session will discuss the role and perspective of state medical boards in the oversight of opioid therapy for pain management.

9:00am – 9:45am

Maximizing the Effectiveness and Safety of Opioids

Pain is among the most common complaints in primary care, including those with chronic symptoms. Taken as prescribed, opioids can be used to manage pain safely and effectively. They are cost effective and allow increased numbers of patients to return to active productive lives in society. Yet, while opioids have been with us for over 4,000 years, the landscape of opioid therapies is rapidly evolving. New formulations and treatment options are emerging that may reduce inherent risk to patients. Education is key to staying current and maximizing the effectiveness of opioids in clinical practice. Topics will include characteristics about various opioids, untangling the complexities of applying opioid conversions to patient care, and more.

9:45am – 10:15am

Networking & Refreshments Break

10:15am – 11:00am

Behavioral Health: Increasing Access to Care Treatment and Services

Behavioral health is an important means to unite the diverse components of an individual’s care in order to insure that care, treatment and services provided are accessible, family-centered, continuous, comprehensive, coordinated, compassionate and culturally effective. With the advent of healthcare reform, an increasing number of behavioral healthcare organizations have sought to offer integrated primary healthcare for the individuals and families that they serve. This session will discuss the decision making process for behavioral healthcare organizations considering offering integrated care, with a focus on how the provision of medication assisted treatment is included in that process.

11:00am – 11:45am

Communicating Messages to Influence Public Perception

Opioid treatment programs have been the target of negative public opinion and adverse media coverage. This has affected the ability to effectively influence national drug policy, explain the science of opioid addiction and treatment, gain the funding necessary to provide quality treatment to all who require it, and ultimately operate in the best interests of patients and communities. This session will address key messages specifically designed to counter the stigma and stereotypes deeply embedded in the perception of opioid addiction and medication-assisted treatment.

11:45am – 12:30pm

Improving Access to Addiction Care

While connecting people to treatment and recovery support has been shown to be effective and can save lives, the addiction care system continues to face tremendous change and upheaval. This session will review recent developments aimed at improving access to addiction care, including medication-assisted treatment. Topics will include:

- Potential future developments related to substance use disorder treatment
- The future of medication assisted treatment, delivery system reforms, and opportunities available for improving policy moving forward
- Strategies for getting ahead of the problem, and how upstream prevention action can restore hope and lead to a brighter and healthier future for generations to come

12:30pm

Conference Concludes

Workshop – Tuesday, September 10, 2019

TBD

Featured Speakers

Jake Nichols, PharmD, MBA

Jake Nichols, PharmD, MBA

Chief Executive Officer

Strategic Recovery Resources, LLC

John A. Johnson, MD, MBA, FACP

John A. Johnson, MD, MBA, FACP

Chief Medical Officer

Virginia Premier

Paul A. Sloan, MD

Paul A. Sloan, MD

Professor of Anestesiology, Vice Chair of Research, Associate Program Director, Pain Medicine Fellowship

University of Kentucky Healthcare
Editor-in-Chief
Journal of Opioid Management

Timothy K. Brennan, MD

Timothy K. Brennan, MD

Director, Addiction Institute

Mount Sinai

Leeann K. Webster, RPh, CDE

Leeann K. Webster, RPh, CDE

Assistant Director, Ambulatory Clinical Pharmacy Programs

Geisinger

Susan Hawk, MS, LPCC-S, LSW, CGP

Susan Hawk, MS, LPCC-S, LSW, CGP

System Director-Behavioral Health

Bon Secours Mercy Health

Tyler W. Barrett, MD, MSCI, FACEP, FHRS

Tyler W. Barrett, MD, MSCI, FACEP, FHRS

Associate Professor, Medical Director, Department of Emergency Medicine

Vanderbilt University Medical Center

John Dowdy

John Dowdy

Director

Mississippi Bureau of Narcotics

Matilde Castiel

Matilde Castiel

Commissioner of Health and Human Services

The City of Worcester

Karen DePasquale

Karen DePasquale

Associate Vice President Clinical Affairs and Clinical Business Operations

UPMC Health Plan

Michael C. White, MCJ

Michael C. White, MCJ

Director of Community Programs

Community Medical Services

Lyle R. Fried, CAP ICADC CHC CRRA

Lyle R. Fried, CAP ICADC CHC CRRA

Co-Founder and Chief Executive Officer

The Shores Treatment and Recovery

Timothy A. Munzing, MD

Timothy A. Munzing, MD

Family Medicine Residency Program Director

Kaiser Permanente
Medical Expert Consultant
Drug Enforcement Administration

Eli Schwarz, KOD, DDS, MPH, PhD

Eli Schwarz, KOD, DDS, MPH, PhD

Professor and Chair, Department of Community Dentistry

Oregon Health & Science University School of Dentistry

Michael Frost, MD, FACP, FASAM

Michael Frost, MD, FACP, FASAM

Chief Medical Officer

Longbridge Health Solutions
Medical Director
The Frost Medical Group, LLC

Venue

Fairmont

Fairmont Scottsdale Princess
7575 East Princess Drive
Scottsdale, AZ 85255
480-585-4848
“Mention BRI Network for a Special Discounted Rate of $229/night – Reserve Early!”

Sponsors and Exhibitors

Media Partner

 

 

FAQ

Are there group discounts available?

  • Yes – Register a group of 3 or more at the same time and receive an additional 10% off the registration fee

Are there discounts for Non-Profit/Government Organizations?

  • Yes – please call us at 800-743-8490 for special pricing

What is the cancellation policy?

  • Cancellations received 4 weeks prior to the event will receive a refund minus the administration fee of $225. Cancellation received less than 4 weeks prior to the event will receive a credit to a future event valid for one year.

Can the registration be transferred to a colleague?

  • Yes – please email us in writing at info@brinetwork.com with the colleague’s name and title

Where can I find information on the venue/accommodations?

  • Along with your registration receipt you will receive information on how to make your hotel reservations. You can also visit individual event page for specific hotel information. The conference fee does not include the cost of accommodations.

What is the suggested dress code?

  • Business casual. Meeting rooms can sometimes be cold so we recommend a sweater or light jacket

Request Brochure

Register Your Team Today!

Register Now
Ask A Question

Be A Thought Leader And Share!

Pin It on Pinterest